Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)

This track delves into the pathogenesis, diagnosis, and management of NAFLD and NASH, which represent a growing public health concern globally. Researchers investigate risk factors, disease progression, novel diagnostic biomarkers, and therapeutic strategies aimed at preventing liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC) in patients with NAFLD/NASH.

    Related Conference of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)

    July 25-26, 2024

    3rd International Conference on Gastroenterology and Liver

    Amsterdam, Netherlands
    November 21-22, 2024

    23rd World Congress on Gastrointestinal Cancer

    Dubai, UAE

    Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in